Search

everythinglearnresearchcommunity

for

Search:↓

A woman developed thick gums from everolimus treatment after a kidney transplant.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Seborrheic dermatitis significantly lowers quality of life, especially in young people, women, and those with higher education.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Psychological factors significantly impact alopecia areata.

Dermatologists diagnose and manage melanoma more effectively than general practitioners.

Consistent use of natural methods is key for healthy hair and scalp.

Children with alopecia areata and their caregivers experience significant emotional and quality of life challenges.

Alopecia areata affects quality of life more than androgenetic alopecia.

Androgenic alopecia significantly affects adults' quality of life, especially in men and employed individuals.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Androgenetic alopecia affects men's emotions more than symptoms or daily function.

A SALT score of ≤ 20 indicates meaningful improvement in alopecia areata treatment.

Alopecia after COVID-19 negatively impacts quality of life, especially vitality.

Alopecia areata negatively affects family life, mental health, and quality of life in young people.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Alopecia greatly lowers the quality of life for South African Black women, especially affecting their self-image and social interactions.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

Alopecia areata significantly worsens quality of life in children, causing embarrassment and social issues.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Alopecia greatly affects Greek women's daily life, relationships, and self-image, with mixed social support and dissatisfaction with treatments.